Vimentin (VIM) antibody

Details for Product No. ABIN268427
Request Want additional data for this product?

The Independent Validation Initiative strives to provide you with high quality data. Find out more

Antigen
Synonyms CTRCT30, cb28, VIM, Vimentin, vim, vime
Reactivity
Human, Mouse (Murine), Rat (Rattus)
(443), (166), (154), (85), (78), (54), (44), (18), (12), (11), (10), (9), (6), (5), (5), (2), (2), (1), (1), (1), (1), (1), (1)
Host
Chicken
(229), (229), (25), (9), (7), (5), (4)
Clonality
Polyclonal
Conjugate
Un-conjugated
(17), (15), (9), (4), (4), (4), (4), (4), (4), (4), (4), (4), (3), (2), (2), (2), (2), (1), (1)
Application
Immunofluorescence (IF), Immunohistochemistry (Paraffin-embedded Sections) (IHC (p)), Western Blotting (WB)
(364), (161), (145), (144), (90), (87), (48), (44), (40), (37), (6), (3), (3), (3), (3), (2), (2), (1), (1)
Pubmed 3 references available
Catalog no. ABIN268427
Quantity 25 µL
Price
Contact our Customer Service for availability and price in your country.
Shipping to United States (Change)
Add to Basket

Order hotline:

  • +1 404 474 4654
  • +1 888 205 9894 (TF)
Immunogen The immunogen used to generate our antibody was recombinant vimentin purified fromE. coli.
Specificity Species Reactivity: ABIN152563 reacts with Vimentin from human, mouse, and rat.
Alternative Name Vimentin
Background Vimentin is the 10nm or intermediate filament protein subunit found in many kinds ofmesenchymal and epithelia cells, in many kinds of cells in tissue culture and indeveloping neuronal and astrocytic precursor cells in the central nervous system.Vimentin frequently forms copolymers with other intermediate filament proteins, such asGFAP (in many kinds of astrocytes), with desmin (in muscle cells) and neurofilamentproteins (in developing neurons). Antibodies to vimentin are useful in studies of stemcells and generally to reveal the filamentous cytoskeleton. Alternate Names: anti-FLJ36605 antibody, anti-VIM antibody.
Gene ID 7431
Research Area Lineage Markers, Cytoskeleton, Neural Stem Cell marker, Cell/Tissue Markers
Application Notes Suggested working dilutions: immunofluorescence 1:5000,Immunohistochemistry-Paraffin 1:150
Restrictions For Research Use only
Format Liquid
Buffer Preservative: 5mM Sodium Azide.
Preservative Sodium azide
Precaution of Use This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
Storage 4 °C
General Rankin, Tomaszewski, Haase: "Renal cyst development in mice with conditional inactivation of the von Hippel-Lindau tumor suppressor." in: Cancer research, Vol. 66, Issue 5, pp. 2576-83, 2006 (PubMed).

Okawa, Michaylira, Kalabis et al.: "The functional interplay between EGFR overexpression, hTERT activation, and p53 mutation in esophageal epithelial cells with activation of stromal fibroblasts induces tumor development, invasion, and differentiation." in: Genes & development, Vol. 21, Issue 21, pp. 2788-803, 2007 (PubMed).

Johnstone, Mongroo, Rich et al.: "Parvin-beta inhibits breast cancer tumorigenicity and promotes CDK9-mediated peroxisome proliferator-activated receptor gamma 1 phosphorylation." in: Molecular and cellular biology, Vol. 28, Issue 2, pp. 687-704, 2008 (PubMed).

Hosts (229), (229), (25), (9), (7), (5), (4)
Reactivities (443), (166), (154), (85), (78), (54), (44), (18), (12), (11), (10), (9), (6), (5), (5), (2), (2), (1), (1), (1), (1), (1), (1)
Applications (364), (161), (145), (144), (90), (87), (48), (44), (40), (37), (6), (3), (3), (3), (3), (2), (2), (1), (1)
Conjugates (17), (15), (9), (4), (4), (4), (4), (4), (4), (4), (4), (4), (3), (2), (2), (2), (2), (1), (1)
Epitopes (20), (18), (16), (15), (8), (8), (6), (5), (5), (4), (4), (4), (4), (2), (2), (2), (2), (2), (2), (2), (2), (2), (1), (1), (1), (1), (1), (1), (1), (1), (1), (1), (1), (1), (1), (1), (1)
Request Want additional data for this product?

The Independent Validation Initiative strives to provide you with high quality data. Find out more

Add to Basket

Order hotline:

  • +1 404 474 4654
  • +1 888 205 9894 (TF)
Validation Images
back to top